Comparing neurocognitive impairment in schizophrenia and bipolar I disorder using the Screen for Cognitive Impairment in Psychiatry Scale

The purpose of this study was to compare the psychometric properties of the Screen for Cognitive Impairment in Psychiatry (SCIP) when applied to patients diagnosed with schizophrenia (n = 126) or bipolar I disorder (n = 76), and also to compare the cognitive impairment in both samples of patients an...

Descripción completa

Detalles Bibliográficos
Autores: Gómez Benito, Juana, Guilera, Georgina, Pino, Oscar, Tabarés Seisdedos, Rafael, Martínez Arán, Anabel, Crespo Facorro, Benedicto|||0000-0001-9709-1276
Tipo de recurso: artículo
Fecha de publicación:2014
País:España
Institución:Universidad de Cantabria (UC)
Repositorio:UCrea Repositorio Abierto de la Universidad de Cantabria
Idioma:inglés
OAI Identifier:oai:repositorio.unican.es:10902/10275
Acceso en línea:http://hdl.handle.net/10902/10275
Access Level:acceso abierto
Palabra clave:Cognitive impairment
Screen for congnitive
Impairment in Psychiatry
Schizophrenia
Bipolar disorder
Instrumental study
Descripción
Sumario:The purpose of this study was to compare the psychometric properties of the Screen for Cognitive Impairment in Psychiatry (SCIP) when applied to patients diagnosed with schizophrenia (n = 126) or bipolar I disorder (n = 76), and also to compare the cognitive impairment in both samples of patients and a control group (n = 83) using the SCIP and a complete neuropsychological battery. The SCIP is a scale intended to quickly and easily assess cognitive impairment in patients with severe psychiatric disorders. The results showed firstly that, in terms of internal consistency, temporal stability, dimensional structure, and criterionreferenced validity, the SCIP provides reliable and valid scores at an equivalent level in both schizophrenia and bipolar I disorder samples. Secondly, it showed that differential cognitive impairment between the two patient groups occurs only in verbal memory, although the effect